Publication Date:
2013-05-24
Description:
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells Cell Death and Disease 4, e641 (May 2013). doi:10.1038/cddis.2013.165 Authors: M R Milone, B Pucci, F Bruzzese, C Carbone, G Piro, S Costantini, F Capone, A Leone, E Di Gennaro, M Caraglia & A Budillon
Keywords:
P38-MAPKdrug resistancezoledronic acidprostate cancer
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink